Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5401_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
344 Herbal Pharmacopeia
Shen, Y.J., Zhang, Z.W., Luo, X.G., Wang, X.F., & Wang, H.L. (2008). Nanoparticles of traditional Chinese
herbs inhibit thrombosis in vivo. Haematologica, 93, 1457. Shukla, N.D., & Tiwari, M. (2011). Proniosomal drug delivery systems – Clinical applications. Int J Res
Pharmaceut Biomed Sci, 2, 880–7. Song, Y.M., Ping, Q.N., & Wu, Z.H. (2005). Preparation of silybin nano emulsion and its pharmacokinetics in
rabbits. J Chin Pharm Univ, 5, 427–31. Sterer, N., Nuas, S., Mizrahi, B., Goldenberg, C., Weiss, E.I., Domb, A, et al. (2008). Oral malodor reduction
by a palatal mucoadhesive tablet containing herbal formulation. J Dent, 36, 535–9. Sungthongjeen, S., Puttipipatkhachorn, S., Paeratakul, O., Dashevsky, A., & Bodmeier, R. (2004). Development
of pulsatile release tablets with swelling and rupturable layers. J Control Release, 95, 147–59. Suresh, S., & Jain, V. (2016). Recent advances in herbal drug delivery systems and the challenge of bioavail-
ability. J Pharm Sci, 105(8), 2505–2512. Tangri, P., & Khurana, S. (2011). Niosomes: Formulation and evaluation. Int J Biopharm, 2, 47–53. Tanwar, Y.S., Gupta, G.D., & Ramawa, K.G. (2006). Development and evaluation of microparticles of
Gugulipid. The Pharma Review. New Delhi: Kongposh Publications Pvt., Ltd., p. 124–32. Touitou, E., Godin, B., Dayan, N., Weiss, C., Piliponsky, A., & Levi- Schaffer, F., et al. (2001). Intracellular
delivery mediated by an ethosomal carrier. Biomaterials, 22, 3053–9. Verma, M., Gupta, P.K., Varsha, B.P., & Purohit, A.P. (2007). Development of transdermal drug dosage formu-
lation for the anti- rheumatic ayurvedic medicinal plants. Anc Sci Life, 11, 66–9. Vicentini, F.T., Simi, T.R., Del Ciampo, J.O., Wolga, N.O., Pitol, D.L., & Iyomasa, M.M., et al. (2008).
Quercetin in w/o microemulsion: In vitro and in vivo skin penetration and efcacy against UVB- induced
skin damages evaluated in vivo. Eur J Pharm Biopharm, 69, 948–57. Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006). The emerging nanomedicine landscape. Nat Biotechnol,
24(10), 1211–1217. Walve, J.R., Bakliwal, S.R., Rane, B.R., & Pawar, S.P. (2011). Transfersomes: A surrogated carrier for trans-
dermal drug delivery system. Int J Appl Biol Pharm Technol, 2, 204–13. Xiao- Ying, L., Luo, J.B., Yan, Z.H., Rong, H.S., & Huang, W.M. (2006). Preparation and in vitro and in vivo
evaluations of topically applied capsaicin transfersomes. Zhongguo Zhong Yao Za Zhi, 31, 981–4. Zhao, H.R., Wang, K., Zhao, Y., & Pan, L.Q. (2002). Novel sustained- release implant of herb extract using
chitosan. Biomaterials, 23, 4459–62. Zhaowu, Z., Xiaoli, W., Yangde, Z., & Nianfeng, L. (2009). Preparation of matrine ethosome, its percutaneous
permeation in vitro and anti- inammatory activity in vivo in rats. J Liposome Res, 19, 155–62. Zhong, H., Deng, Y., Wang, X., & Yang, B. (2005). Multivesicular liposome formulation for the sustained deliv-
ery of breviscapine. Int J Pharm, 301, 15–24.
Targeted Delivery Systems
16
forHerbal Drugs
Rizwan Ullah Khan and Syeda Pakeeza Fatima Naqvi
Institute of Chemical Sciences, Gomal University, D.I. Khan, Pakistan
Yubao Chen
Deputy Secretary General, Chinese Society of Biotechnology, China
Sohail Ahmad
Gomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan, Pakistan

16.1 FUNDAMENTALS OF HERBAL DRUG DELIVERY SYSTEMS

In recent years, herbal medicines have gained the worldwide attention of peoples and researchers due to their esthetic value, increased patient compliance and prominent therapeutic effects. Novel drug delivery systems for the delivery of herbal drugs possesses several advantages over conven­tional formulations. These include, among others, the enhancement of solubility, bioavailability, and protection from toxicity (Prajakta N. Dongare et al., 2021). The herbal drugs can be used in a more upright course with enhanced efcacy by incorporating them into suitable dosage forms (Guo et al.,
2023). This can be achieved by designing novel drug delivery systems for such drugs. Such systems include liposomes, polymeric nanoparticles, micelle, nanocapsules, phytosomes, carbon nanotubes, DNA nano carriers, and aptamers- based delivery.
There has been an increased advancement in the eld of herbal drug delivery systems, especially with the incorporation of the nanotechnology. This integration is intended to improve the solubility, effectiveness, and safety of the herbal products in which the different active compounds often have low solubility and bioavailability levels because of their complex molecular structures. Many of the preventive and curative formulations in the traditional system demand a greater amount of drugs to produce the desired therapeutic efcacy which invariably leads to more side effects and poor patient compliance. Some challenges require to be overcome in the development of herbal drugs through nanotechnology, which may enhance the pharmacokinetic properties of herbal extracts and deliver them to precise sites within the body. The application of nanotechnology in the herbal drug delivery system (HDDS) can effectively address these challenges. Nanotechnology- based drug delivery sys­tems (NDDS) have been proven to be a revolutionary strategy to improve the medicinal efcacy of herbal drugs. These systems employ carriers in the nano range that are created using liposomes, solid lipid nanoparticles (SLNs), and polymeric nanoparticles to encapsulate valuable active con­stituents present in herbs. Moreover, it helps to enhance the efcacy prole of the active compounds mainly due to improved stability, solubility and bioavailability. This is because it has been discov­ered that nanoparticles of comparatively insoluble herbal extracts could improve their biopharma­ceutical properties; in other words, the bioavailability of the compound, thereby optimizing therapeutic efciency for minimum dosing (Jalili et al., 2023; Dewi et al., 2022; Verma et al., 2018). Further, it offers exibility in minimizing the frequency of administration which may ease the
345
346 Herbal Pharmacopeia
compliance of the treatment regimens especially compounded by the complex nature of the tradi­tional herbal preparation dosage (Ambwani et al., 2018; Onyeji, 2022). This has also been made possible by the development of nano- sized herbal drug systems because the physicochemical barri­ers hampering the effectiveness of herbal remedies are also well addressed by this invention. A majority of the herbal constituents have been shown to be of low aqueous solubility and high molec­ular weights and thus cannot easily diffuse across biological membranes. These compounds, when formulated using nanotechnology, can be delivered in the form of nanoparticles that could easily cross lipid membranes and therefore augment their bioavailability (Kesarwani & Gupta, 2013; Azzahra et al., 2020). For instance, ethosomes and transfersomes are suggested to be a better method of transdermal delivery of herbal drugs, leading to better absorptive ability through the skin and a better response from the drugs (Chen et al., 2022; Rahman et al., 2020). Moreover, the application of nanocarriers in the system of herbal drug delivery enable the controlled and prolonged releases of the drug. This slow release is benecial for the constant release of therapeutic drugs and regular upkeep of their blood concentration, thereby increasing patient compliance, especially in the context of compound chronic diseases (Jalali, 2022; Razavi, 2024). It is also possible to control the physi­cochemical properties of these nanocarriers so that they only release the herbal compounds at the desired site and time in response to some physiological stimuli such as pH or temperature (Bonifácio et al., 2013; Ansari et al., 2012). Indeed, nanotechnology is used in the improvement of the bioavail­ability of the active ingredients, controlled release and reduction of toxicity levels as associated with herbal medicines. The problem with these compounds is that they have several adverse effects. However, when herbal extracts are enclosed in nanoparticles, which are biocompatible and biode­gradable, several of these issues are mostly likely to be avoided. This is specically the case with plant extracts as these too may possess powerful biological effects, but are equally likely to cause toxicity when given in large doses (Darji et al., 2022; Wani et al., 2015). One advantage that is coupled with NDDS is the potential to give smaller concentrations of the active pharmaceutical ingredients but to give cure dosages. Furthermore, advances in technology has seen nanotechnology incorporated into the herbal medicine, which has provided a way through which diseases can be treated. Because the interaction between nanoparticles and tissues or cells depends on surface chem­istry, researchers can modify the surface chemistry of nanoparticles so as to have a higher afnity to certain tissues or cells, thus enabling pharmacists to deliver herbal drugs to the desired location, such as tumors or inamed tissues (Marella & Prasad, 2018; Gunasekaran et al., 2014). It also increases the therapeutic effectiveness and therapeutic window of the herbal medicine while mini­mizing the occurrence of systemic side effects and related risks to patients, thereby increasing patients’ safety (Metkari, 2023; Gopi & Amalraj, 2016). The following are some of the real- life examples of nanotechnology in herbal drug delivery: Route of administration here also plays a sig­nicant role, the common routes being oral, transdermal and intravenous. Every route has its advan­tages and problems in terms of the improvement of delivery of the herbal products. For instance, oral delivery systems can be designed to protect herbal compounds from degradation in the gastrointes­tinal tract, while transdermal systems can facilitate the direct absorption of active ingredients through the skin (Arsude, 2023). Nanogels, and especially nanoemulsions have demonstrated improvements in stability and bioavailability of herbal formulations for numerous therapeutic uses (Alharbi et al., 2021).

16.1.1 AdvAntAges of HerbAl drugs

Herbal formulations are preparations composed of one or more herbs or processed herbs, designed to provide nutritional, cosmetic, or therapeutic benets for humans or animals. These formulations are produced through processes such as the extraction, distillation, or fermentation of whole plants, plant parts, or their derivatives, resulting in products like powders, tinctures, extracts, oils, and juices (Elkordy et al., 2021).
Targeted Delivery Systems for Herbal Drugs 347
Herbal drugs have gained signicant attention in recent years because of the various advantages that come with it as a natural product over chemically synthesized drugs. These benets includes factors like: safety, effectiveness, cost and the prospect for fewer side effects. It is evident that the usage of herbs has constantly improved time by time due to the fact that these treatments have been used for thousands of years by the Ayurveda and traditional Chinese medicine practices. The use of herbal drugs has a number of benets. of which one is that they are safe to use. Some of the herbal medicines are obtained from natural products, and thus it has been established that they have been in use for generations. When compared with synthetic drugs, the latter more frequently have severe side effects and toxicities (Kumari et al., 2021; Murshed et al., 2023; Zhou et al.,
2017). This safety is especially benecial where chronic conditions require long- term use of the intervention in question. For example, it has been conrmed that the herbal medicine is quite use­ful in the treatment and control of rheumatoid arthritis and there are fewer side effects compared to the traditional medicine (Li, et al., 2022; Vyshnevska et al., 2022). Economy is another advan­tage of herbal drugs that cannot be over- emphasized. In general, the cost of producing herbal medi­cine and procuring them is cheaper than synthesizing chemical- based medicines hence can reach many people (Akintelu et al., 2021; Murshed et al., 2023). This affordability is particularly impor­tance in the low- income zones because people may not have adequate healthcare. Also, people that take herbal medicine do so at their own expense, hence they are less likely to burden the healthcare system with numerous charges, especially in the case of chronic diseases as they seek medical attention using these natural products, which are often cheaper than chemically produced drugs (Murshed et al., 2023; Mohammadi et al., 2020). Another factor that supports the effectiveness of herbal drugs is versatility of the preparation since they are often composite by nature. Most herbal medicines may contain several active ingredients which may, in a way, complement each other in an effort to boost their efcacy. Such mechanism of action of herbal drugs helps them modulate several pathways in the body, a valuable characteristic in treating complicated diseases such as cancer and diabetes (Yin et al., 2013; Yang et al., 2018). For instance, studies have suggested that herbal medicines enhance the body’s ability to ght infections, also enhance the general well- being of cancer patients even if they use conventional treatments (Yin et al., 2013). In addition, the for­mulation of herbal drugs can be improved using newer concepts like phytosomes and nanocarriers. These new and complex drug delivery systems can enhance the dissolution and bioavailability of herbal ingredients, thereby enhancing therapeutic efcacy as reported by a number of researchers (Nandhini and Ilango, 2021; Gaikwad et al., 2021; Dongare et al., 2021). When such technologies are incorporated in the application of these plants, the curative value of the medicinal herbs can be enhanced, and therefore function as potential substitutes or adjuncts to modern synthetic drugs. However, the two options come with certain qualities that are linked with the usage of the herbal drugs; they have therapeutic values; they are also said to be holistic in the treatment. Most natural remedies for diseases are compounded in such a way that in addition to curing a particular disease, they help maintain health and harmony in the body. This view is of the whole- person approach which characterizes traditional systems of medicine and more so Ayurveda, where the focus is not on treating disease but on managing the affected individual. In addition, awareness regarding herbal medicines has grown signicantly, creating awareness into formulation to expose new active ingredients and therapeutic uses. This is because this ongoing research is useful for the conrma­tion of the effectiveness of these herbal drugs destined for modern medicine and to establish their safety for use (Mohammadi et al., 2020; Kuruüzüm- Uz et al., 2012; Razavi, 2024). For instance, researchers have established that a number of phytochemicals possess strong anti- inammatory and antioxidant characteristics that are useful for medical use (Kuruüzüm- Uz et al., 2012; Abo­Zeid et al., 2021). While appreciating the benets of herbal drugs, one should not close eyes to the problem attendant with their use. Among the challenges that need to be considered are standardiza­tion, quality assurance and control, as well as possible herb–drug interactions (Dragos et al., 2017; Ogawa- Ochiai & Kawasaki, 2019).
348 Herbal Pharmacopeia

16.1.2 CHAllenges of HerbAl drugs

Around the globe to date, an estimated 422,000 species of plants have so far been identied for medicinal purposes. Of this total number, some 52,000 (around 12.5%) plant species are currently being used for different medical purposes. 4160 (nearly 8%) of the medicinally important plants are kept in the ‘threatened’ category. Many of these plants have not yet been fully explored for their true biological activities. Only a few of the plants have been identied, well- characterized and listed in ofcial pharmacopoeias (Pan, 2014).
Therefore, herbal medicines and drugs are not without disadvantages, and hence, they cannot be applicable to all disease conditions. Although herbal drugs offer a lot of advantages, there is a down­side as well, with some serious risks being associated with the consumption of herbal drugs (Studdert, et al. 1998).
With developments in biomedical sciences, advancements in isolation and characterization tech­niques, in vivo and in vitro studies, toxicological studies, novel drug delivery mechanisms and deeper understanding of biological systems, along with the discovery of new therapeutic targets in bodies, drug discovery overall remains a lengthy, very expensive, laborious, and inefcient process. Hence, there is still a low rate of new therapeutic drug discovery (Tang, K., 2011).
There are several notable challenges associated with the herbal drugs, including:
a. The regulations of herbal drugs. The US Food and Drug Administration (FDA) has much
more stringent rules for the manufacturers of pharmaceutical drugs than are applied to herbal manufacturers.
b. Herbal drugs interact and interfere with other drugs and foodstuffs, which may cause seri-
ous, harmful effects (Raynor D. K 2011).
c. The lack of dosage instructions leads to either low dosage or over dosage since people take
herbal medication by self- dosing.
d. Herbal drugs may pose serious allergic reactions. Before using herbal medicines, one must
ensure the allergic test for that herbal drug. Conventional medicines are taken with a pre­scription, so they pose lower risks of allergy.
e. One major issue associated with herbal formulations is their adulteration with foreign
substances like steroids and heavy metals. This can lead to serious renal problems.
The shelf- life of herbal medicines is another big issue. The herbal medicines are a mixture of differ­ent chemical substances. The variety of phytoconstituents may differ in terms of properties such as shelf- life, pharmacokinetics, and pharmacodynamics. Changes in these properties alter the biologi­cal actions of a drug. Currently, available knowledge cannot address these disadvantages of herbal formulations (Izzo, A. A. 2004).

16.1.3 rise of tArgeted delivery for HerbAl drugs

The targeted drug delivery system is a technique that enables us to deliver the drug to the designated site of action and has a signicant effect on the medicine’s efcacy. What comes into play here is the role and the bioavailability at the target site alongside specic herbal drug activity (Dongare etal., 2021).
Traditional drug delivery strategies (oral, nasal, or transdermal injections as different routes of administration) display systemic adverse side effects (Hassan and Zhang, 2019). These effects may include inconsistent drug release, or off- target and non- specic biodistribution, which may disrupt the overall drug- targeting mechanism. Hence, the development of new drug delivery system facili­tates the controlled release of drug payloads at the target site. Novel drug delivery systems can reduce herbal drug dosing frequency while keeping the drug concentration in the targeted cells, organs or tissue for a prolonged period (Singh & Sharma, 2023).
Targeted Delivery Systems for Herbal Drugs 349
In the preceding sections, we will dive deeper into different carrier systems and detailed mecha­nisms involving the drug delivery systems overall, with the specic context of herbal drugs.

16.2 CARRIERS SYSTEMS FOR TARGETED DRUGS

Targeted drug delivery (TDD) is a precise method of delivering drugs directly to specic areas of the body, thereby reducing side effects and improving treatment effectiveness. TDD uses various car­riers, such as polymers, nanoparticles, liposomes, and micelles, to transport drugs to their intended targets. The drug carrier systems used for the purpose of targeted drug delivery are in fact tiny cargo­carrying vehicles that transport drugs/active compounds or herbal compounds to a specic location in the body. The drug cargo- carrying vehicles are designed in such a way that they support the safe and controlled release of the drug molecules at the target site. They also avoid unloading the drug off target (Dunuweera, 2019).
Nanotechnology and nanomedicine are making great contributions to revolutionizing the horizon of drug delivery. The purpose of these domains of research is to offer better drug targeting as well as safe and controlled release of the drug compounds. Traditional delivery systems have many short­comings, which include rapid drug release from cell or target site and low specicity. Nanotechnology offers a lot of variety in the form of nanocarriers, which provide a very precise and efcient way to transport drugs to their intended target sites.
Nanocarriers offer a variety of chemistries and combinations. Different polymers (bio- based poly­mers and inorganic polymers or a mixture of both), nanoparticles (metallic, non- metallic, biological), and liposomes (phospholipids) may all act as tiny delivery vehicles that enhance drug delivery, target­ing, and safe release & effectiveness. By reducing side effects and minimizing adverse effects, nano­medicine offers a promising approach for improving the effective treatment of a number of diseases. Overall, nanocarriers enhance the cellular update of drug and therapeutic outcomes.
In this section, we will discuss liposomes, polymeric nanoparticles, nanocapsules and nano­spheres, polymeric micelles, dendrimers, carbon nanotubes, aptamers, and DNA nanocarriers. We will discuss the currently used drug carriers as well as explaining the exciting domains of DNA nanotechnology and functional nucleic acids as potential drug delivery vehicles. These relatively new elds of science and biomedical research have not yet been explored and herbal drugs are not making full use of the potential of these elds.

16.2.1 liposome- mediAted drug delivery system

Liposomal drug delivery systems can be considered to be one of the most signicant advancements in the pharmaceutical sciences, especially in relation to the optimization of the pharmacodynamics and pharmacokinetic characteristics of different drugs. These systems incorporate liposomes which are spherical vesicles consisting of a lipid bilayer and are capable of encapsulating both aqueous soluble and water- insoluble drugs, thereby enhancing their stability, solubility, and pharmacokinetic properties. The relative size and shape of liposomes can be used to release their contents gradually and with a low risk of undesirable side effects at loci tissues, organs, and cells where the encased agents need to act (Gumulec et al., 2014; Smits et al., 2018). An important advantage of liposomal formulations is that they can improve the solubility and stability of compounds which are poorly sol­uble in water. For example, doxorubicin encapsulation in liposomal formulations was demonstrated to increase its therapeutic window through a decreased cardiotoxic effect without compromising the cancer cell- killing potential (Gumulec et al., 2014; Smits et al., 2018). This entrainment not only shields the drug from being degraded but also assists the drug in crossing biological membranes, thereby boosting its bioavailability. This has been done to show that liposomal formulations can produce a higher plasma level of drugs than the non- encapsulated drugs, which in turn enhance the therapeutic effects (Yi et al., 2013; Nogueira et al., 2015b). In addition, liposomes can be designed to have the capabilities of passive or active targeting of tissues or cells. Passive targeting makes use
350 Herbal Pharmacopeia
of what is known as the enhanced permeability and retention (EPR) effect, whereby, liposomes are allowed to penetrate and adhere to tumor tissues due to the hyperpermeability of their blood vessels (Shigehiro et al., 2014; Sercombe et al., 2015). Active targeting, however, concerns the alteration of liposomal surfaces with ligands that can interact with receptors present over the targeted cells, such as folic acid receptors in cancer cells Nogueira et al., 2015a). It not only increases the accumulation of the drug at the targeted site but also decreases the side effects at the other sites, further improving the overall safety of the treatment (Niu et al., 2015). The formulation versatility of liposomal deliv­ery systems is an added bonus to the versatility of the system. Liposomes can incorporate almost any pharmacologic agents in their core or incorporated in the bilayer, such as small molecules, peptides, proteins, and nucleic acids for delivery (Akbarzadeh et al., 2013; Schwendener & Schott,
2017). Such exibility also enable a technology that can encapsulate several drugs simultaneously, which is benecial when the drugs are administered together in the cases of chronic illnesses such as cancer. For instance, the ability to deliver chemotherapeutic agent and siRNA simultaneously using liposomes has been found to improve the effectiveness of overall treatment also lower the dosages of each agents (Niu et al., 2015; Grace, 2014). In addition to its uses in therapy, liposomes have also been considered as carriers for vaccines. Liposomes have the capability to successfully delivering antigens and improve the immunogenicity of vaccines. This is well informed by the development of liposomal adjuvants for the enhancement of immune response to co- administered antigens, which is a process that is discussed by Schwendener & Schott (2017). Liposomes possessing capacity to encapsulate both the hydrophilic and the hydrophobic component make them a suitable approach for developing new vaccine formulations. Although the liposomal drug delivery systems have been associated with many benets, there are several challenges that need to be overcome for the system to have higher value in clinical applications. One major concern is the low percentage of encapsula­tion that is sometimes reported with certain drugs, hence conning the benets of liposome formula­tions (Skrinda et al., 2021; Sreekanth et al., 2017). There are great disparities in lipid composition, preparation methods, and drug properties which inuence the efciency of encapsulation and release kinetics (Teong et al., 2014; Pentak et al., 2011). The continual study is directed towards modifying these parameters to optimize situations with liposomal systems. In addition, the tendency of liposo­mal formulations to degrade in the course of storage, and their compatibility during administration, is of the essence. Liposomes are liable to aggregation, fusion, and leakage out of the sheltered phar­maceutical, and that again will affect its usefulness (Guimarães et al., 2019; Pauli et al., 2019). Other approaches include the addition of stabilizers or the employment of the microuidic technology for the improvement of liposomal formulations’ shelf stability (Elsana et al., 2019; Zheng et al., 2022).
More recently, advancements in liposome- mediated drug delivery have centered on bioconjuga­tion strategies. Liposomes, a widely used nanoparticle carrier, have been modied to improve drug loading, targeting, and overall efcacy. These improvements aim to enhance the delivery of thera­peutic agents to various sites of action (Almeida et al., 2020).
Despite all the potential applications of liposomes, the development and application of liposomes remain a challenge due to their complex production processes. Researches are being carried out with the aim to overcome these hurdles (Farooque et al., 2021).

16.2.2 polymeriC nAnopArtiCles As drug CArriers

Polymeric nanoparticles rang in size from 1 to 1000 nm. These nanoparticles can be loaded with either drugs or active compounds. The loaded compounds are either trapped inside or absorbed onto the surface of the polymeric core (Zielinska, A.,2020). The term ‘nanoparticle’ can be used in the cases of both nanospheres and nanocapsules. Nanocapsules are made up of an oily core. In this oily core the drug is dissolved. The core is encircled by a polymeric shell, which controls the release of the entrapped drug from the core. By contrast, s nanospheres contain a continuous polymeric net­work. The loaded compound drug may be retained inside the core or adsorbed onto the surface of
Targeted Delivery Systems for Herbal Drugs 351
FIGURE 16.1 a) Liposome Hydrophobic heads towards the outside and hydrophilic tails towards the inner core, drug molecule in the center. b) Polymeric Nanoparticle, drug molecule in centre, Nanocapsule and Nanosphere shown containing the drug molecules. c) Phytosome with drug molecules . d) Polymeric Micelle, drug molecules, Targeting agent in green, moiety sensitive to stimuli, polymeric coat e) Dendrimer, upper left side without modication of functional groups, positively and negatively charged groups in, hydrophobic drug and nucleic acid shown. Upper right side, modication with different agents’ amino acid, antibody and protein. Lower right side, modication with carbon nanotube. Lower left side, modication with PEGylation, f) Carbon Nanotube carrying different types of cargo, g) Barrel shaped DNA origami, structure made up of scaffold and staple strands, different cargos can be loaded on to origami, the cargo is injected in mice to deliver drugs to target site.
nanosphere (see Figure 16.1b). Essential oils have been efciently delivered by polymeric nanopar­ticles (Lammari N., 2020).
The main characteristics of polymeric NPs, are that they are biocompatible and biodegradable and that they pose low- toxicity risks (Pinelli F., 2020).
According to a study conducted by Maurya et al. (2019), polymeric NPs can be safely used by humans. Similarly, polymeric NPs can signicantly improve the bioavailability of the loaded drugs. They are stable and can encapsulate large amounts of guest molecules. Recent studies on biodegrad­able and non- biodegradable polymers suggest that both type of polymeric nanocarriers can be used for oral drug delivery (Maurya A., 2019).
It is worthwhile mentioning here the successful study in which pure curcumin was compared with curcumin- loaded polymeric NPs. The polymeric formulation provided 5.6-fold higher oral bioavailability (Chen, Y., 2020).
Polymeric nanoparticles are emerging as a groundbreaking solution to address the complexities of drug delivery. Key advantages of polymeric nanoparticles include enhanced bioavailability, targeted delivery, controlled release, and versatility. Applications include cancer therapy, ocular drug delivery,
352 Herbal Pharmacopeia
and nutraceutical delivery. The eld of polymeric nanoparticles is rapidly evolving as scientists con­tinue to explore the potential of these innovative materials. We can expect to see even more exciting advancements in drug delivery in the years to come (Begines et al., 2020).
Polymeric nanoparticles show promise in cancer treatment. They can deliver drugs directly to tumors, thereby reducing side effects and improving therapeutic outcomes. These nanoparticles have potential applications in various cancers: ovarian, colorectal and others, and brain tumors (Madej et al., 2022).
Nanoparticles can be modied to improve their effectiveness and they are being explored for various therapeutic applications (Dristant et al., 2023).

16.2.3 miCelles

Polymeric micelles are promising nanocarriers for the delivery of anticancer drugs, offering advan­tages such as targeted drug delivery, improved biocompatibility, and reduced side effects. (Elumalai et al., 2024).
Micelles involve self- assembly techniques. Micellar carriers are used in vast nanomedicine appli­cations. They involve techniques, including:
• Interaction with biological substances
• Kinetic stability
• Drug release
These techniques are crucial for understanding drug delivery systems (Ghezzi et al., 2021).
Polymeric micelles are promising nanocarriers for delivering anticancer drugs. They can encap­sulate both hydrophilic and hydrophobic drugs and release them in a controlled manner.
Micelles are useful for delivering different anticancer drugs. Considering factors such as meth­ods and computational analysis, micelles are promising nanomaterials that can be used to target drug delivery (Guzmán Rodríguez et al., 2023. Physically, micelles are uorescent materials that exhibit enhanced emission when aggregated. They have various applications in bioimaging, drug delivery, and therapy (Liu et al., 2023). Micelles are useful nanostructures that can be used in the targeting of cancer treatment. They can deliver both drugs and genes, enhancing cancer therapy. Various types of smart micelles, including pH- sensitive and multi- responsive micelles, can be used for targeted drug delivery. The combination of micelles and nanostructures can further enhance their potential in cancer treatment. Studies have shown that micelles are highly compatible and safe (Gao et al., 2024).

16.2.4 dendrimers

Dendrimers are highly branched polymers. They were rst developed in 1978 by Buhleier et al., when they were named cascade polymers. These cascade polymers laid the foundation of polypro­pylene imine dendrimers, which were developed in the 1990s. The name dendrimer is derived from the Greek words ‘dendron,’ which means tree or branch, and ‘meros.’ Which means part.
At molecular level, dendritic branching gives a semiglobular or globular structure to the den­drimer. The surface contains a small molecular volume with a high density of functionalities. The structure of a typical dendrimer comprises three different structural parts (see Figure 16.1e):
a. Core at the center (either a single atom or an atomic group), having at least two identical
chemical functions.
b. Building blocks providing numerous interior layers made up of repeating units. It provides
exible space to different guest molecules.
Targeted Delivery Systems for Herbal Drugs 353
c. Multiple functional groups at the peripheries of macromolecule exteriorly. It plays the
major key role in the overall properties of the dendrimer. This part denes the macroscopic properties of the dendrimer.
This structural assembly and overall 3D structural complex of dendrimers confers unique proper­ties, such as a globular shape at the nanoscale, functional groups at the peripheries, hydrophilic and hydrophobic cavities in the interior, and low polydispersity.
The globular structures, and the diameter of less than 10 nm, is very similar to the molecular size of biomolecules and proteins. Hence dendrimers act as biomimics. Overall, dendrimers provide structural complexities along with opportunities for accommodating and carrying drug molecules, targeting moieties like antibodies, and solubilizing groups like PEG on the surface (see Figure 16.1e).
Dendrimers have demonstrated their potential as nanocarriers for different types of drugs like antimicrobial, anticancer, and anti- inammatory drugs.

16.2.5 CArbon nAnotubes And fullerenes

Carbon nanotubes (which are abbreviated as CNTs) have a cylindrical shape. The sheets of carbons are, in fact, hexagonally ordered carbon atoms. This structural feature gives the nanotubes a diam­eter of few nanometers and length ranges of up to a few micrometers. Carbon nanotubes may be either single- walled (SWCNTs) or multi- walled (MWCNTs) (Zare, H., 2021).
Structurally, carbon nanotubes are hollow nanobers, and this structural characteristic makes them attractive candidates for the delivery of drugs and diagnostic agents. Similarly, other properties of CNTs including high biocompatibility, enhanced conductivity, high surface- to- volume ratios, ease of functionalization, strength, and optical properties (Serpell, C. J., 2016) make them novel drug delivery carriers (see Figure 16.1f).
The biggest concerns associated with the use of CNTs in the eld of biomedical sciences have centered around two main issues, biodegradability and toxicity.
In addition to these negative features of carbon nanotubes, a lot of research is still being carried out in this domain of science. Among the notable applications of CNTs are their functions in the elds of biosensors, drug delivery systems, bioimaging, vaccine delivery, gene delivery, gene ther­apy and diagnostic applications (Mahor, A., 2021).
Fullerene is an allotrope of carbon and usually described as a molecular form of carbon. In fuller­ene, carbon atoms (n > 20) are clustered on a spherical surface. The most studied of these forms is fullerene C60. The water solubility of fullerenes can be improved through the grafting and function­alization of different chemical groups. In this way new drugs can be obtained. Different studies have been reported in which functionalized fullerenes have been used for therapeutic and diagnostics applications. Functionalized derivatives of fullerenes are mainly focused in the areas of quenching reactive oxygen species (ROS), drug delivery and bioimaging (Debnath, S. K., 2021).
But keeping the real- life concern in biomedical sciences, the eld of CNT still has a long way to go due to the inaccurate and relatively low number of toxicity studies (Nimushakavi, S., 2021). Nevertheless, it is hoped that more research in the coming times will make CNTs workable. In this respect, herbal medicines can benet from this domain of nanotechnology for drug delivery purposes.

16.2.6 pHytosomes

Phytosomes are lipid- based complexes of herbal drug/plant extract with phospholipids. It’s a rela­tively new technology, being invented by Indena in 1989. Another name for phytosomes is phyto­phospholipid complexes. The name itself is self- explanatory, since it describes the interaction between herbal drug/phyto compounds and the hydrophilic parts of phospholipids through hydrogen bonds (see Figure 16.1c).